Nutrien (NYSE:NTR) Issues Quarterly Earnings Results

Nutrien (NYSE:NTR) posted its quarterly earnings results on Wednesday. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09), Briefing.com reports. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business had revenue of $10.81 billion during the quarter, compared to analyst estimates of $10.44 billion. During the same period last year, the firm posted $2.65 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis.

Nutrien Price Performance

Shares of NTR traded down $0.16 during midday trading on Thursday, reaching $66.76. The stock had a trading volume of 3,009,547 shares, compared to its average volume of 3,190,199. Nutrien has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. The firm’s 50 day moving average price is $66.21 and its 200-day moving average price is $70.47. The company has a market capitalization of $31.93 billion, a P/E ratio of 13.60, a P/E/G ratio of 0.67 and a beta of 0.61.

Nutrien Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. Nutrien’s dividend payout ratio (DPR) is 44.81%.

Nutrien News Roundup

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Nutrien’s board declared a quarterly dividend of US$0.55 per share, payable October 16 to shareholders of record September 29. The payment supports the stock’s income appeal and represents an annualized yield of approximately 3.3%. Nutrien Declares Quarterly Dividend of US$0.55 per Share
• Positive Sentiment: Second-quarter revenue reached approximately $10.81 billion, up 3.6% year over year and above the $10.44 billion consensus estimate. The company also generated strong operating cash flow and continued investing in its operations, indicating resilience in its core fertilizer businesses. Nutrien Releases Q2 2026 Earnings
• Neutral Sentiment: Analyst price targets remain above the current trading level in many cases, with a reported six-month median target of $82. However, the range is wide, including a $65 target, reflecting differing views on fertilizer pricing and Nutrien’s earnings outlook. Nutrien Price Targets and Institutional Activity
• Negative Sentiment: Nutrien reported quarterly EPS of $2.61, below the $2.70 consensus estimate and down from $2.65 a year earlier. The earnings miss is likely outweighing the revenue beat, particularly as lower sales and higher costs pressured profitability. Nutrien Q2 Earnings Miss Estimates

Analyst Ratings Changes

A number of brokerages recently commented on NTR. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Thursday, April 30th. UBS Group lowered their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a research report on Monday, May 11th. JPMorgan Chase & Co. increased their price objective on shares of Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. TD Securities reissued a “buy” rating on shares of Nutrien in a research note on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Nutrien from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, June 1st. Sixteen investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $81.84.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Sfam LLC acquired a new position in shares of Nutrien in the 4th quarter worth $37,000. Geneos Wealth Management Inc. raised its holdings in shares of Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after acquiring an additional 219 shares during the period. Fulcrum Asset Management LLP acquired a new position in Nutrien in the 3rd quarter worth approximately $46,000. Acadian Asset Management LLC acquired a new position in Nutrien in the 1st quarter worth approximately $54,000. Finally, Arax Advisory Partners grew its position in Nutrien by 23.5% during the 4th quarter. Arax Advisory Partners now owns 1,525 shares of the company’s stock worth $94,000 after purchasing an additional 290 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.